Last updated on January 2019

Exercise Capacity Study of LCZ696 vs. Enalapril in Patients With Chronic Heart Failure and Reduced Ejection Fraction.


Brief description of study

The purpose of the study is to determine the effect of LCZ696 vs. Enalapril on improvement of excercise capacity in patients with chronic heart failure with reduced ejection fraction

Clinical Study Identifier: NCT02768298

Contact Investigators or Research Sites near you

Start Over

Novartis Pharmaceuticals

Novartis Investigative Site
Berlin, Germany
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Bonn, Germany
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Dresden, Germany
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Erfurt, Germany
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Essen, Germany
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Freiburg, Germany
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Goettingen, Germany
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Guetersloh, Germany
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Hamburg, Germany
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Heidelberg, Germany
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Kiel, Germany
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Koblenz, Germany
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Koeln-Nippes, Germany
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Koeln, Germany
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Leverkusen, Germany
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Ludwigshafen, Germany
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Muehlheim an der Ruhr, Germany
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Muenchen, Germany
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Neuwied, Germany
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Nienburg, Germany
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Oldenburg, Germany
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Rotenburg an der Fulda, Germany
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Siegen, Germany
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Ulm, Germany
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Worms, Germany
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Wuppertal, Germany
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Muehlheim An Der Ruhr, Germany
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Regensburg, Germany
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Villingen-Schwenningen, Germany
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Wuerzburg, Germany
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Frankfurt, Germany
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Mainz, Germany
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Ludwigsburg, Germany
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Coburg, Germany
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Hannover, Germany
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Mönchengladbach, Germany
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Rüdersdorf, Germany
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.